Devdatt Kurdikar News Today

Cacti Asset Management LLC lessened its holdings in Embecta Corp. (NASDAQ:EMBC – Free Report) by 7.2% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 61,088 shares of the company’s stock after selling 4,723 shares during the period. Cacti Asset Management LLC owned approximately […]

Principal Financial Group Inc. lessened its position in Embecta Corp. (NASDAQ:EMBC – Free Report) by 3.3% during the first quarter, Holdings Channel reports. The institutional investor owned 353,613 shares of the company’s stock after selling 12,076 shares during the quarter. Principal Financial Group Inc.’s holdings in Embecta were worth $9,944,000 as of its most recent […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) shares gapped down prior to trading on Thursday after Morgan Stanley lowered their price target on the stock from $19.00 to $16.00. The stock had previously closed at $17.65, but opened at $17.28. Morgan Stanley currently has an underweight rating on the stock. Embecta shares last traded at […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) declared a quarterly dividend on Tuesday, August 8th, Zacks reports. Investors of record on Friday, August 25th will be given a dividend of 0.15 per share on Wednesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 3.48%. The ex-dividend date is Thursday, August […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) CEO Devdatt Kurdikar purchased 5,000 shares of the company’s stock in a transaction on Thursday, August 10th. The stock was acquired at an average price of $21.81 per share, with a total value of $109,050.00. Following the completion of the purchase, the chief executive officer now directly owns […]

Embecta Corp. (NASDAQ:EMBC – Get Free Report) CEO Devdatt Kurdikar bought 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The shares were acquired at an average price of $21.81 per share, with a total value of $109,050.00. Following the purchase, the chief executive officer now owns 244,791 shares […]

Embecta Corp. is looking for acquisitions. Devdatt Kurdikar, Chief Executive Officer said during the Fiscal First Quarter 2023 Earnings Conference Call, "And finally, we also have our eye on the... | February 15, 2023

Nearly one year after BD (NYSE:BDX) announced its intent to spinoff its diabetes business, Embecta (Nasdaq:EMBC) now stands on its own.

The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.

BD's independent, publicly traded company for its Diabetes Care business will be called embecta, Becton Dickison & Co. announced.